- Home
- NTRA vs FWONK Comparison
NTRA vs FWONK Comparison
Compare NTRA & FWONK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRA
- FWONK
- Stock Information
- Founded
- NTRA 2003
- FWONK 1950
- Country
- NTRA United States
- FWONK United States
- Employees
- NTRA N/A
- FWONK N/A
- Industry
- NTRA Medical Specialities
- FWONK Broadcasting
- Sector
- NTRA Health Care
- FWONK Industrials
- Exchange
- NTRA Nasdaq
- FWONK Nasdaq
- Market Cap
- NTRA 18.4B
- FWONK 21.4B
- IPO Year
- NTRA 2015
- FWONK N/A
- Fundamental
- Price
- NTRA $148.08
- FWONK $82.79
- Analyst Decision
- NTRA Strong Buy
- FWONK Buy
- Analyst Count
- NTRA 17
- FWONK 6
- Target Price
- NTRA $176.65
- FWONK $97.17
- AVG Volume (30 Days)
- NTRA 1.6M
- FWONK 1.4M
- Earning Date
- NTRA 05-08-2025
- FWONK 05-07-2025
- Dividend Yield
- NTRA N/A
- FWONK N/A
- EPS Growth
- NTRA N/A
- FWONK N/A
- EPS
- NTRA N/A
- FWONK N/A
- Revenue
- NTRA $1,696,911,000.00
- FWONK $3,653,000,000.00
- Revenue This Year
- NTRA $15.33
- FWONK $14.51
- Revenue Next Year
- NTRA $18.50
- FWONK $6.77
- P/E Ratio
- NTRA N/A
- FWONK N/A
- Revenue Growth
- NTRA 56.75
- FWONK 13.38
- 52 Week Low
- NTRA $83.13
- FWONK $66.90
- 52 Week High
- NTRA $183.00
- FWONK $102.33
- Technical
- Relative Strength Index (RSI)
- NTRA 50.83
- FWONK 46.21
- Support Level
- NTRA $125.38
- FWONK $76.06
- Resistance Level
- NTRA $152.66
- FWONK $80.60
- Average True Range (ATR)
- NTRA 8.82
- FWONK 3.97
- MACD
- NTRA 1.47
- FWONK -0.04
- Stochastic Oscillator
- NTRA 82.19
- FWONK 49.57
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
About FWONK Liberty Media Corporation Series C Liberty Formula One
Liberty Media Corp along with its subsidiaries is engaged in the media and entertainment industries in North America and the United Kingdom. The company owns interests in a high-quality portfolio of assets across the media, entertainment and sports industries. The company derives its maximum revenue from United Kingdom.